Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.
Jhawar SR, Wang SJ, Thandoni A, Bommareddy PK, Newman JH, Marzo AL, Kuzel TM, Gupta V, Reiser J, Daniels P, Schiff D, Mitchell D, LeBoeuf NR, Simmons C, Goyal S, Lasfar A, Guevara-Patino JA, Haffty BG, Kaufman HL, Silk AW, Zloza A, Giurini EF.
Jhawar SR, et al. Among authors: silk aw.
J Immunother Cancer. 2023 Jul;11(7):e006780. doi: 10.1136/jitc-2023-006780.
J Immunother Cancer. 2023.
PMID: 37433716
Free PMC article.